Potential Risks of Plant-based Dietary Supplements: A Closer Look at Liver Toxicity and Safety Concern

Dietary supplements, which include a wide range of products such as vitamins, minerals, herbs, and botanicals, are commonly used to complement regular diets and provide nutritional or physiological benefits. Among these, plant-based supplements like Echinacea, Ginkgo Biloba, Ginseng, and Green Tea Extract (GTE) have gained significant popularity for their therapeutic uses. However, certain plant-based supplements have been linked to liver toxicity, raising concerns about their safety. Green tea extract, commonly consumed for its antioxidant properties and weight-loss claims, has been associated with acute liver injury, with case reports documenting jaundice and elevated liver enzymes in affected individuals. Other supplements, such as Kava, Germander, and certain weight-loss products, also carry risks of hepatotoxicity due to mechanisms involving oxidative stress, DNA interaction, and depletion of protective enzymes like glutathione. Herbal products, including Herbal life, have been implicated in liver damage, leading to clinical symptoms such as jaundice, fatigue, and elevated liver enzymes. Additionally, Comfrey, a plant known for its medicinal use, contains pyrrolizidine alkaloids that can result in severe liver damage, including cirrhosis. These findings highlight the need for caution when using plant-based supplements, particularly when consumed in excess or in combination with other medications. Despite the growing demand for alternative therapies, more research and regulatory oversight are necessary to ensure the safety of these products and prevent adverse health outcomes. Major Findings: The major findings highlight that while dietary supplements, particularly plant-based products, offer health benefits; many are associated with hepatotoxicity and other adverse effects. Green tea extract, kava, germander, and Herbal life products have been linked to liver damage, often due to toxic metabolites, oxidative stress, and drug interactions. Regulatory gaps and in

View article page

Download PDF